Avacta Group Share News (AVCT)
AVCT Share
AVCT Share
AVCT Share
AVCT Share
AVCT
AVCT Share
AVCT Level 2
AVCT Live
AVCT Broker
AVCT Directors
AVCT Financial
AVCT
AVCT Short
AVCT
Last checked at -
LONDON, June 22 (Reuters) - A weekly coronavirus testing regime using a "no-swab" saliva test is being trialled in Southampton, southern England, and could result in a simpler and quicker way to detect outbreaks of the virus, the British governme...
Read more
(Sharecast News) - Avacta Group announced on Thursday that collaborative work with the Centre for Virus Research at the University of Glasgow has shown that its 'Affimer' reagents, which bind to the SARS-COV-2 (Covid-19) virus spike protein, prevent infection of human cells by a SARS-COV-2 model virus, and therefore provide a potential therapy for Covid-19 infection.
Read more
UK Shareholder Meetings Calendar - Next 7 Days
Read moreUK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test
Read more(Sharecast News) - Avacta said its Covid-19 antigen test had reached prototype stage and could detect the virus in model samples.
Read moreAvacta To Raise GBP48 Million To Accelerate Development Of Therapies
Read more(Sharecast News) - Biotherapeutic and reagent developer Avacta Group announced its intention to raise up to £45m through a placing to institutional and other investors, a direct subscription with the company, and offers to retail and other investors via the PrimaryBid platform, it announced on Thursday.
Read more(Sharecast News) - Avacta Group has entered into an exclusive distribution agreement with Medusa19 for direct-to-consumer sales of a saliva-based rapid test for the Covid-19 antigen, it announced on Wednesday.
Read moreUK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations
Read more(Sharecast News) - Biotherapeutics developer Avacta Group shipped out reagents for Covid-19 antigen testing to its diagnostic test development partners on Monday.
Read moreAvacta Group Reports Widened Loss Amid Higher Operating Expenses
Read moreUK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests
Read more(Sharecast News) - Biotherapeutics developer Avacta has entered into a collaboration agreement with American firm Adeptrix to develop a high throughput Covid-19 antigen test using its proprietary bead-assisted mass spectrometry (BAMS) platform.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreUK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order
Read more
Last checked at